Bond.az White LogoBond.az Black Logo
→
EN ▾
AZENRU
IOC Q4 2026 earnings beat expectationsAnalysis: World awaits new Fed Chair's vision on independenceEagle Materials stock gains 3% on Q4 earnings beatUS SEC rescinds policy on denials of wrongdoingHikmat Hajiyev: Azerbaijan is a favorable venue for international eventsNapoli coach revolution: Who will replace Conte?Presidential aide: Azerbaijan is diplomatic hubRashad Nabiyev: More Roads Don't Solve TrafficBilibili earnings beat estimates by ¥0.25Knorr-Bremse upgraded on cheap valuationIOC Q4 2026 earnings beat expectationsAnalysis: World awaits new Fed Chair's vision on independenceEagle Materials stock gains 3% on Q4 earnings beatUS SEC rescinds policy on denials of wrongdoingHikmat Hajiyev: Azerbaijan is a favorable venue for international eventsNapoli coach revolution: Who will replace Conte?Presidential aide: Azerbaijan is diplomatic hubRashad Nabiyev: More Roads Don't Solve TrafficBilibili earnings beat estimates by ¥0.25Knorr-Bremse upgraded on cheap valuation
Personalize
Bond.az White LogoBond.az Black Logo
AZENRU

#jazz-pharmaceuticals

Latest news and interesting information about jazz-pharmaceuticals.

UBS Upgrades Jazz Pharma on Ziihera Potential
Today / 09:11
|
441

UBS Upgrades Jazz Pharma on Ziihera Potential

UBS upgrades Jazz Pharmaceuticals to Buy with a $307 target on Ziihera potential. Bond.az provides detailed analysis and stock insights.

ANALYST RATINGS →
0
...